The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells

Journal of Cranio-Maxillofacial Surgery

Volumn 40, Issue 8, 2012, Pages

  Acil Y ^a   Moller B ^a   Niehoff, P ^a   Rachko, K ^a   Gassling, V ^a   Wiltfang, J ^a   Simon, M J K ^a  

^a Campus Kiel ^*  (Germany)

Author keywords

Bisphosphonates; Gingival fibroblasts; Human osteoblasts; In vitro; Osteogenic sarcoma cells; Osteonecrosis

Indexed keywords

ALENDRONIC ACID; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; FOLLOW UP; GINGIVA; HUMAN; HUMAN CELL; IN VITRO STUDY; JAW OSTEONECROSIS; MOUTH CAVITY; OSTEOBLAST; OSTEOSARCOMA CELL;

ALENDRONATE; ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN TYPE I; COLORING AGENTS; DIPHOSPHATES; DIPHOSPHONATES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FOLLOW-UP STUDIES; GINGIVA; HUMANS; IMIDAZOLES; OSTEOBLASTS; OSTEOCALCIN; OSTEOSARCOMA; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84869490626     PISSN: 10105182     EISSN: 18784119     Source Type: Journal    
DOI: 10.1016/j.jcms.2011.10.024     Document Type: Article

References (60)

1. M.H. Abu-Id, P.H. Warnke, J. Gottschalk, I. Springer, J. Wiltfang, and Y. Acil "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw J Craniomaxillofac Surg 36 2008 95 103
2. Y. Açil, and P.K. Müller A rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) J Chromatogr A 664 1994 183 188
3. Y. Acil, H. Terheyden, A. Dunsche, B. Fleiner, and S. Jepsen Three-dimensional cultivation of human osteoblast-like cells on highly porous natural bone mineral J Biomed Mater Res 51 2000 703 710
4. Y. Acil, I.N. Springer, V. Broek, H. Terheyden, and S. Jepsen Effects of bone morphogenetic protein-7 stimulation on osteoblasts cultured on different biomaterials J Cell Biochem 86 2002 90 98
5. Y. Acil, A.E. Mobasseri, P.H. Warnke, H. Terheyden, J. Wiltfang, and I. Springer Detection of mature collagen in human dental enamel Calcif Tissue Int 76 2005 121 126
6. Y. Acil, I.N. Springer, P. Niehoff, V. Gassling, P.H. Warnke, and S. Acmaz Proof of direct radiogenic destruction of collagen in vitro Strahlenther Onkol 183 2007 374 379
7. H. Agis, J. Blei, G. Watzek, and R. Gruber Is zoledronate toxic to human periodontal fibroblasts? J Dent Res 89 2010 40 45
8. American Association of Oral and Maxillofacial Surgeons American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 65 2007 369 376
9. S. Bocanegra-Pérez, M. Vicente-Barrero, M. Sosa-Henríquez, A. Gebaguer Blanco, M. Knezevic, and J.M. Castellano-Navarro [Osteonecrosis of the jaw secondary to oral alendronate: report of three cases] Rev Med Chil 137 2009 275 279
10. M.M. Bornstein, N. Cionca, and A. Mombelli Systemic conditions and treatments as risk for implant therapy Int J Oral Maxillofac Implants 24 Suppl. 2009 12 27
11. V. Breuil, F. Cosman, L. Stein, W. Horbert, J. Nieves, and V. Shen Human osteoclast formation and activity in vitro: effects of alendronate J Bone Miner Res 13 1998 1721 1729
12. A.M. Cafro, L. Barbarano, A.M. Nosari, G. D'Avanzo, M. Nichelatti, and M. Bibas Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid Clin Lymphoma Myeloma 8 2008 111 116
13. C.M. Capeci, and N.C. Tejwani Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy J Bone Joint Surg Am 91 2009 2556 2561
14. R.E. Coleman Metastatic bone disease: clinical features, pathophysiology, and treatment strategies Cancer Treat Rev 27 2001 165 176
15. M. Degidi, and A. Piattelli Immediately loaded bar-connected implants with an anodized surface inserted in the anterior mandible in a patient treated with diphosphonates for osteoporosis: a case report with a 12-month follow-up Clin Implant Dental Relat Res 5 2003 269 272
16. B.J. Edwards, J.W. Hellstein, P.L. Jacobsen, S. Kaltman, A. Mariotti, and C.A. Migliorati American Dental Association Council on Scientific Affairs Expert Panel on Bisphosphonate-Associated Osteonecrosis of the Jaw. Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs J Am Dent Assoc 139 2008 1674 1677
17. G. Ficarra, F. Beninati, I. Rubio, A. Vannucchi, G. Longo, and P. Tonelli Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment J Clin Periodontol 32 2005 1123 1128
18. H. Fleisch Bisphosphonates: mechanisms of action Endocr Rev 19 1998 80 100
19. A. Goss, M. Bartold, P. Sambrook, and P. Hawker The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series J Oral Maxillofac Surg 68 2010 337 343
20. A.R. Holmberg, U.H. Lerner, A.A. Alayia, M. Al-Mohanna, C. Adra, and M. Marquez Development of novel ploy bisphosphonate conjugate for treat of skeletal metastasis and osteoporosis Int J Oncol 37 2010 563 567
21. J.W. Hong, W. Nam, I.H. Cha, S.W. Chung, H.S. Choi, and K.M. Kim Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia Osteoporos 21 2010 847 853
22. G.N. Hortobagyi, R.L. Theriault, L. Porter, D. Blayney, A. Lipton, and C. Sinoff Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases N Engl J Med 335 1996 1785 1791
23. A.I. Idris, J. Rojas, I.R. Greig, R.J. van't Hof, and S.H. Ralston Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro Calcif Tissue Int 82 2008 191 201
24. G.-I. Im, S.A. Qureshi, J. Kenney, H.E. Rubash, and A.S. Shanbhag Osteoblast proliferation and maturation by bisphosphonates Biomaterials 25 2004 4105 4115
25. M. Ito, M. Chokki, Y. Ogino, Y. Satomi, Y. Azuma, and T. Ohta Comparison of cytotoxic effects of bisphosphonates in vitro and in vivo Calcif Tissue Int 63 1998 143 147
26. I.S. Jamall, V.N. Finelli, and S.S. Que Hee A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues Anal Biochem 112 1981 70 75
27. F. Journé, N. Kheddoumi, C. Chaboteaux, H. Duvillier, G. Laurent, and J.-J. Body Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells Breast Cancer Res 10 2008 R4 (Epub 2008 Jan 11)
28. L. Junquera, L. Gallego, P. Cuesta, A. Pelaz, and J.C. de Vincente Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases Am J Otolaryngol 30 2009 390 395
29. Y. Kobayashi, T. Hiraga, A. Ueda, L. Wang, M. Matsumoto-Nakano, and K. Hata Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice J Bone Miner Metab 28 2010 165 175
30. F.P. Koch, S.S. Yekta, C. Merkel, T. Ziebart, and R. Smeets The impact of bisphosphonates on the osteoblast proliferation and collagen gene expression in vitro Head Face Med 6 2010 12
31. S.K. Kumar, M.C. Meru, and P.P. Sedghizadeh Osteonecrosis of the jaws secondary to bisphosphonate therapy: a case serious J Contemp Dent Pract 9 2008 63 69
32. P. Lesclous, S. Abi Najm, J.P. Carrel, B. Baroukh, T. Lombardi, and J.P. Willi Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone 45 2009 843 852 (Epub 2009 Jul 22)
33. J.C. Lo, F.S. O'Ryan, N.P. Gordon, J. Yang, R.L. Hui, and D. Martin Predicting risk of osteonecrosis of the jaws with oral bisphosphonate exposure (PROBE) investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure J Oral Maxillofac Surg 68 2010 243 253 (Epub 2009 Sep 24)
34. S.P. Luckman, D.E. Hughes, F.P. Coxon, R. Graham, G. Russell, and M.J. Rogers Nitrogen-containing bisphosphonates inhibit the mevalonate path-way and prevent post-translational prenylation of GTP-binding pro-teins, including Ras J Bone Miner Res 13 1998 581 589
35. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1118
36. R.E. Marx, Y. Sawatari, M. Fortin, and V. Broumand Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 2005 1567 1575
37. T. Matsumoto, H. Hagino, M. Shiraki, M. Fukunaga, T. Nakano, and K. Takaoka Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study Osteoporos Int 20 2009 1429 1437
38. T. Mayrokokki, A. Cheng, B. Stein, and A. Goss Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 2007 415 423
39. C. Morgan, S. Jeremiah, and J. Wagstaff Metronomic administration of ibandronate and ist anti-angiogenic effects in vitro Microvasc Res 78 2009 453 458 (Epub 2009 Aug 6)
40. G.H. Nancollas, R. Tang, R.J. Phipps, Z. Henneman, S. Gulde, and W. Wu Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite Bone 38 2006 617 627
41. P. Niehoff, J. Wiltfang, I.N. Springer, N. Weppner, B. Kimmig, and Y. Acil Increased excretion of collagen crosslinks in irradiated patients indicates destruction of collagen Int J Radiat Biol 82 2006 503 509
42. A.M. Pabst, T. Ziebart, F.P. Koch, K.Y. Taylor, B. Al-Nawas, and C. Walter The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes - in vitro study Clin Oral Invest Jan 12, 2011 (Epub ahead of print)
43. S. Ponader, H. Brandt, E. Vairaktaris, C. von Wilmowsky, E. Nkenke, and K.A. Schlegel In vitro response of hFOB cells to pamidronate modified sodium silicate coated cellulose scaffolds Colloids Surf B Biointerfaces 64 2008 275 283
44. P.M. Purcell, and I.W. Boyd Bisphosphonates and osteonecrosis of the jaw Med J Aust 182 2005 417 418
45. B. Ramaswamy, and C.L. Shapiro Bisphosphonates in the prevention and treatment of bone metastasis Oncology 17 2003 1261 1270
46. M.J. Ravosa, J. Ning, Y. Liu, and M.S. Stack Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts Arch Oral Biol 56 2011 491 498 (Epub 2010 Dec 10)
47. I.R. Reid Osteonecrosis of the jaw - who gets it, and why? Bone 44 2009 4 10
48. M.J. Rogers, S. Gordon, H.L. Benford, F.P. Coxon, S.P. Luckman, and J. Monkkonen Cellular and molecular mechanisms of action of bisphosphonates Cancer 88 2000 2961 2978
49. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534
50. R. Russell Bisphosphonates: from bench to bedside Ann N Y Acad Sci 1068 2006 367 401
51. F. Saad, D.M. Gleason, R. Murray, S. Tchekmedyian, P. Venner, and L. Lacombe Zoledronic acid prostate cancer study group. A randomized, placebo controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma J Natl Cancer Inst 94 2002 1458 1468
52. D. Santini, B. Vincenzi, R.A. Hannon, J.E. Brown, G. Dicuonzo, and S. Angeletti Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours Oncol Rep 15 2006 1351 1357
53. J. Schilcher, and P. Aspenberg Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate Acta Orthop 80 2009 413 415
54. P.P. Sedghizadeh, S.K. Kumar, A. Gorur, C. Schaudinn, C.F. Shuler, and J.W. Costerton Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy J Oral Maxillofac Surg 66 2008 767 775
55. P.P. Sedghizadeh, K. Stanley, M. Caligiuri, S. Hofkes, B. Lowry, and C.F. Shuler Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry J Am Dent Assoc 140 2009 61 66
56. M.J.K. Simon, P. Niehoff, B. Kimmig, J. Wiltfang, and Y. Acil Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment Clin Oral Invest 14 2010 51 58
57. Y. Suzuki, T. Nishiyama, K. Hasuda, T. Fujishiro, T. Nikura, and S. Hayashi Effect of etidronate on COX-2 expression and PGE2 production in macrophage-like RAW 264.7 cells stimulated by titanium particles J Orthop Sci 12 2007 568 577 (Epub 2007 Nov 30)
58. C. Walter, M.O. Klein, A. Pabst, B. Al-Nawas, H. Duschner, and T. Ziebart Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells Clin Oral Invest 14 2010 35 41
59. J. Wood, K. Bonjean, S. Ruetz, A. Bellahcène, L. Devy, and J.M. Foidrat Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid J Pharmacol Exp Ther 302 2002 1055 1061
60. N. Yarom, T.S. Lazarovici, and S. Elad Oral bisphosphonate-related osteonecrosis of the jaw: incidence, clinical features, prevention, and treatment recommendations Clinic Rev Bone Miner Metab 8 2010 27 31 (Epub 2009 Jul 09)